342 related articles for article (PubMed ID: 12857602)
1. Role of interleukin-15 and interleukin-18 in the secretion of sIL-6R and sgp130 by human neutrophils.
Jablonska E; Marcinczyk M
Mediators Inflamm; 2003 Jun; 12(3):179-83. PubMed ID: 12857602
[TBL] [Abstract][Full Text] [Related]
2. Role of soluble gp130 in the tumour necrosis factor-alpha expression and its production by peripheral blood mononuclear cells.
Jablonskaca E; Puzewska W; Marcinczyk M; Jablonski J
Mediators Inflamm; 2003 Dec; 12(6):355-9. PubMed ID: 14668095
[TBL] [Abstract][Full Text] [Related]
3. Effect of soluble interleukin-6 receptor alpha and interleukin-6 secreted by polymorphonuclear leukocytes on tumor necrosis factor-alpha expression and its production by peripheral blood mononuclear cells.
Jablonska E
Mediators Inflamm; 2002 Oct; 11(5):325-8. PubMed ID: 12467526
[TBL] [Abstract][Full Text] [Related]
4. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
[TBL] [Abstract][Full Text] [Related]
5. Effect of IL-18 on IL-1beta and sIL-1RII production by human neutrophils.
Jabłońska E; Izycka A; Wawrusiewicz N
Arch Immunol Ther Exp (Warsz); 2002; 50(2):139-41. PubMed ID: 12022703
[TBL] [Abstract][Full Text] [Related]
6. Effect of IL-18 on the release of IL-6 and its soluble receptors: sIL-6Ralpha and sgp130 by human neutrophils.
Jablonska E; Jablonski J
Immunol Invest; 2002; 31(3-4):159-67. PubMed ID: 12472176
[TBL] [Abstract][Full Text] [Related]
7. Effect of IL-15 on the secretion of IL-1beta, IL-1Ra and sIL-1RII by PMN from cancer patients.
Jablonska E; Piotrowski L; Kiluk M; Jablonski J; Grabowska Z; Markiewicz W
Cytokine; 2001 Dec; 16(5):173-7. PubMed ID: 11814312
[TBL] [Abstract][Full Text] [Related]
8. [Determination of serum soluble interleukin-6 receptor and soluble gp130 levels in patient with pregnancy induced hypertension and its significance].
Li Y; Wang Y; Qi L
Zhonghua Fu Chan Ke Za Zhi; 2001 Jan; 36(1):18-9. PubMed ID: 11778537
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 receptor signaling. II. Bio-availability of interleukin-6 in serum.
Gaillard J; Pugnière M; Tresca J; Mani J; Klein B; Brochier J
Eur Cytokine Netw; 1999 Sep; 10(3):337-44. PubMed ID: 10477390
[TBL] [Abstract][Full Text] [Related]
10. Relationship between TNF-alpha, IL-6 and their soluble receptors in the cultures of human PMN, PBMC and WBC.
Jabłońska E
Rocz Akad Med Bialymst; 2001; 46():77-86. PubMed ID: 11780583
[TBL] [Abstract][Full Text] [Related]
11. TLR2 expression in relation to IL-6 and IL-1beta and their natural regulators production by PMN and PBMC in patients with Lyme disease.
Jablonska E; Marcinczyk M
Mediators Inflamm; 2006; 2006(1):32071. PubMed ID: 16864901
[TBL] [Abstract][Full Text] [Related]
12. IL-4 production by human polymorphonuclear neutrophils.
Brandt E; Woerly G; Younes AB; Loiseau S; Capron M
J Leukoc Biol; 2000 Jul; 68(1):125-30. PubMed ID: 10914499
[TBL] [Abstract][Full Text] [Related]
13. Soluble gp130 is up-regulated in the implantation window and shows altered secretion in patients with primary unexplained infertility.
Sherwin JR; Smith SK; Wilson A; Sharkey AM
J Clin Endocrinol Metab; 2002 Aug; 87(8):3953-60. PubMed ID: 12161539
[TBL] [Abstract][Full Text] [Related]
14. Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases.
Michalopoulou M; Nikolaou C; Tavernarakis A; Alexandri NM; Rentzos M; Chatzipanagiotou S; Cambouri C; Vassilopoulos D
Immunol Lett; 2004 Jul; 94(3):183-9. PubMed ID: 15275965
[TBL] [Abstract][Full Text] [Related]
15. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling.
Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J
J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558
[TBL] [Abstract][Full Text] [Related]
16. Altered pulmonary interleukin-6 signaling in preterm infants developing bronchopulmonary dysplasia.
von Bismarck P; Claass A; Schickor C; Krause MF; Rose-John S
Exp Lung Res; 2008 Dec; 34(10):694-706. PubMed ID: 19085566
[TBL] [Abstract][Full Text] [Related]
17. [Effect of IL-6/sIL-6R on ex vivo expansion of human cord blood derived CD34+ cells].
Feng JF; Zhuang M; Zhu LJ; Sheng ZL; Zhu YQ; Li CP
Ai Zheng; 2004 Jun; 23(6):715-8. PubMed ID: 15191679
[TBL] [Abstract][Full Text] [Related]
18. IL-15 in the culture supernatants of PMN and PBMC and the serum of patients with Lyme disease.
Jabłońska E; Marcińczyk M; Talarek Ł; Pancewicz S; Hermanowska-Szpakowicz T; Jabłoński J
Rocz Akad Med Bialymst; 2003; 48():78-81. PubMed ID: 14737947
[TBL] [Abstract][Full Text] [Related]
19. Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid.
Desgeorges A; Gabay C; Silacci P; Novick D; Roux-Lombard P; Grau G; Dayer JM; Vischer T; Guerne PA
J Rheumatol; 1997 Aug; 24(8):1510-6. PubMed ID: 9263143
[TBL] [Abstract][Full Text] [Related]
20. [Examination and evaluation of sIL-6R, sgp130 in serum in patients with chronic hepatopathy].
Shang J; Xu Y; Zhang H
Zhonghua Gan Zang Bing Za Zhi; 2000 Apr; 8(2):87-8. PubMed ID: 10861111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
